2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Vascular Malformations
1
Surgical Wound Infection
1
Hemangioma, Capillary
1
Hemangioma
1
Interventions
Timolol
7
Propranolol
7
Lasers, Dye
3
Population Groups
2
Nadolol
2
Imiquimod
2
Atenolol
2
ziprasidone
1
propranolol mustard
1
Zolpidem
1
Warfarin
1
Vecuronium Bromide
1
Vancomycin
1
Ultrasonography
1
Tranexamic Acid
1
Tobramycin
1
Surgery, Computer-Assisted
1
Spironolactone
1
Sevelamer
1
Rocuronium
1
Piperacillin, Tazobactam Drug Combination
1
Pentobarbital
1
Oxycodone
1
Ophthalmic Solutions
1
Ointments
1
Nifedipine
1
Nafcillin
1
Mupirocin
1
Molindone
1
Methylprednisolone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hemangioma, Capillary
×
Mupirocin
×
Clear all
NCT01408056
2014-01-17
TOUCH
Children's Hospital of Philadelphia
Phase 2
Withdrawn